Found: 8
Select item for more details and to access through your institution.
Comparison of timing and decision-makers of do-not-resuscitate orders between thoracic cancer and non-cancer respiratory disease patients dying in a Japanese acute care hospital.
- Published in:
- Supportive Care in Cancer, 2014, v. 22, n. 6, p. 1485, doi. 10.1007/s00520-013-2105-z
- By:
- Publication type:
- Article
Impact of sarcopenia in patients with advanced non-small cell lung cancer treated with PD-1 inhibitors: A preliminary retrospective study.
- Published in:
- Scientific Reports, 2019, v. 9, n. 1, p. 1, doi. 10.1038/s41598-019-39120-6
- By:
- Publication type:
- Article
Selective targeting of multiple myeloma cells with a monoclonal antibody recognizing the ubiquitous protein CD98 heavy chain.
- Published in:
- Science Translational Medicine, 2022, v. 14, n. 632, p. 1, doi. 10.1126/scitranslmed.aax7706
- By:
- Publication type:
- Article
CD98 heavy chain protein is overexpressed in non-small cell lung cancer and is a potential target for CAR T-cell therapy.
- Published in:
- Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-68779-9
- By:
- Publication type:
- Article
Lipoid Pneumonia After Pembrolizumab Treatment for Advanced Non–Small-Cell Lung Cancer.
- Published in:
- Clinical Lung Cancer, 2022, v. 23, n. 2, p. e116, doi. 10.1016/j.cllc.2021.12.003
- By:
- Publication type:
- Article
A case of CD74‐ROS1‐positive lung adenocarcinoma diagnosed by next‐generation sequencing achieved long‐term survival with pemetrexed regimens.
- Published in:
- Thoracic Cancer, 2023, v. 14, n. 25, p. 2618, doi. 10.1111/1759-7714.15041
- By:
- Publication type:
- Article
Identification of glioblastoma-specific antigens expressed in patient-derived tumor cells as candidate targets for chimeric antigen receptor T cell therapy.
- Published in:
- Neuro-Oncology Advances, 2023, v. 5, n. 1, p. 1, doi. 10.1093/noajnl/vdac177
- By:
- Publication type:
- Article
Phase II trial of induction chemotherapy of pemetrexed plus split-dose cisplatin followed by pemetrexed maintenance for untreated non-squamous non-small-cell lung cancer.
- Published in:
- 2018
- By:
- Publication type:
- journal article